In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Marie-Claude POTIER Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Marie-Claude
Last Name:POTIER
Title:Dr
Advanced Degrees:PhD
Affiliation:CNRS-INSERM-UPMC
Department:CRICM
Street Address 1:Pitié-Salpêtrière Hospital
Street Address 2:47, Bd de l'Hôpital
City:Paris
Zip/Postal Code:75013
Country/Territory:France
Phone:+33142162141
Fax:+33142162146
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 7 July 2009]
View all comments by Marie-Claude POTIER
Clinical Interests:
Alzheimer Disease
Research Focus:
DNA microarrays, Genetics, Molecular and Cell biology, Microscopy, Animal Models, Neuropathology, A-beta PP/A-beta, Clinical trials, Neurobiology, Chemistry/Pharmacology, Drug screening, Brain imaging, Neuroimmunology
Work Sector(s):
Research institute
Web Sites:
Professional: www.cnrs.fr
Lab: www.cricm.upmc.fr
Researcher Bio
Marie-Claude Potier
Born 30-03-1961 in Paris

PRESENT POSITION
Directeur de Recherche 2ème classe at CNRS,
Centre de Recherche de l'ICM
UPMC/Inserm UMR_S 975; CNRS UMR 7225
Hôpital de la Pitié Salpétrière
Bât Pharmacie, 5ème étage
47 Bd de l'Hôpital
75013 Paris, France


EDUCATION
2004 Habilitation à Diriger des recherches, University Paris VII
1988 PhD in Neuropharmacology, University Paris VI 1983 Thesis in Pharmacy, University Paris V 1978-1983 Paris V School of Pharmacy

PROFESSIONAL EXPERIENCE
Since 1995 Staff scientist at CNRS (ESPCI, Paris) 19991-1995 Staff scientist at CNRS (Gif-sur-Yvette)
1984-1988 Postdoc Laboratory of Molecular Biology (MRC, Cambridge, UK)
1983-1988 PhD Institut Alfred Fessard (CNRS, Gif-sur-Yvette)
1983-1984 Master M2 Neuropharmacology (ICSN, CNRS,Gif-sur-Yvette)

Top Papers
Potier M.-C, Dutriaux A. et Reeves R. (1996). Use of YAC fragmentation to delimit a duplicated region on human chromosome 21. Mammalian Genome 7:85-88.

Dutriaux A., Rossier J., Van Hull W., Nizetic D., Theophile d., Delabar J., Van Broeckhoven C. et Potier M.-C. (1994). Cloning and characterization of a 135-500kb region of homology on the long arm of human chromosome 21. Genomics 22:472-477.

Potier M.-C, Dutriaux A., R. Orti, J. Groet, N. Gibelin, G. Karadima, G. Lutfalla, A. Lynn, C. Van Broeckhoven, A. Chakravarti, M. Petersen, D. Nizetic, J. Delabar and J. Rossier (1998). Two sequence-ready contigs spanning the two copies of a 200-kb duplication on human 21q: partial sequence and polymorphisms. Genomics 51:417-426.

Golfier G., F. Chibon, A. Aurias, X-N. Chen, J. Korenberg, J. Rossier et M.-C. Potier. (2003) The 200-kb segmental duplication on human chromosome 21 originates from a pericentromeric dissemination involving human chromosome 2, 18 and 13. Gene, 17 : 51-59.

Golfier G., M. Tran Dang, L. Dauphinot, E. Graison, J. Rossier and M.-C. Potier. (2004) VARAN: a web server for VARiability ANalysis of DNA microarray experiments. Bioinformatics, 20:1641-1643.

Dauphinot L, Lyle R, Rivals I, Dang MT, Moldrich RX, Golfier G, Ettwiller L, Toyama K, Rossier J, Personnaz L, Antonarakis SE, Epstein CJ, Sinet PM, Potier MC. (2005) The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. Hum Mol Genet. 14:373-384.

Potier MC., I. Rivals, G. Mercier, L. Ettwiller, R.X. Moldrich, J. Laffaire, L. Personnaz, J. Rossier et L. Dauphinot. (2006) Transcriptional disruptions in Down syndrome : a case-study in the Ts1Cje mouse cerebellum during postnatal development. J. Neurochem. Suppl 1:104-9.

Rivals, I., Personnaz, L., Taing, L. and Potier, MC (2007) Enrichment or depletion of a GO category within a class of genes: which test? Bioinformatics Feb 15;23(4):401-7.

Moldrich, R., Dauphinot, L., Laffaire, J., Rossier, J., and Potier, M.-C. (2007) Down syndrome gene dosage imbalance on cerebellum development. Progress in Neurobiol. 82:87-94.

Ait Yahya-Graison E, Aubert J, Dauphinot L, Rivals I, Prieur M, Golfier G, Rossier J, Personnaz L, Creau N, Blehaut H, Robin S, Delabar JM, Potier MC. (2007) Classification of human chromosome 21 gene-expression variations in down syndrome: impact on disease phenotypes. Am J Hum Genet. 81:475-91.
If resources were not limited, what research projects would you pursue?
AD and Down syndrome
What is your leading hypothesis?
Modification APP endocytosis in AD

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad